NCT03431675View on ClinicalTrials.gov

Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 1, 2019

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2019

Conditions
Meningitis, Meningococcal
Interventions
DRUG

Ciprofloxacin

Single-dose oral ciprofloxacin

Trial Locations (1)

Unknown

Madarounfa Health District, Madarounfa

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

Medecins Sans Frontieres, Netherlands

OTHER

lead

Epicentre

OTHER

NCT03431675 - Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018 | Biotech Hunter | Biotech Hunter